Release Date: 29/11/22 10:22 Summary: Breaker Investor Presentation - RRS Summer Series Price Sensitive: No Download Document 1.6MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%